Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
2.175
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Shanghai Fosun Pharmaceutical Max Drawdown (5Y) : 83.84% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 83.84% |
| April 30, 2026 | 83.84% |
| March 31, 2026 | 83.84% |
| February 28, 2026 | 83.84% |
| January 31, 2026 | 83.84% |
| December 31, 2025 | 83.84% |
| November 30, 2025 | 83.84% |
| October 31, 2025 | 83.84% |
| September 30, 2025 | 83.84% |
| August 31, 2025 | 83.84% |
| July 31, 2025 | 83.84% |
| June 30, 2025 | 83.84% |
| May 31, 2025 | 83.84% |
| April 30, 2025 | 83.84% |
| March 31, 2025 | 83.84% |
| February 28, 2025 | 83.84% |
| January 31, 2025 | 83.84% |
| December 31, 2024 | 83.84% |
| November 30, 2024 | 83.84% |
| October 31, 2024 | 83.84% |
| September 30, 2024 | 83.84% |
| August 31, 2024 | 83.84% |
| July 31, 2024 | 83.84% |
| June 30, 2024 | 83.84% |
| May 31, 2024 | 83.84% |
| Date | Value |
|---|---|
| April 30, 2024 | 83.84% |
| March 31, 2024 | 83.02% |
| February 29, 2024 | 83.02% |
| January 31, 2024 | 82.32% |
| December 31, 2023 | 78.30% |
| November 30, 2023 | 77.18% |
| October 31, 2023 | 77.18% |
| September 30, 2023 | 76.63% |
| August 31, 2023 | 76.63% |
| July 31, 2023 | 76.63% |
| June 30, 2023 | 76.63% |
| May 31, 2023 | 76.63% |
| April 30, 2023 | 76.63% |
| March 31, 2023 | 76.63% |
| February 28, 2023 | 76.63% |
| January 31, 2023 | 76.63% |
| December 31, 2022 | 76.63% |
| November 30, 2022 | 76.63% |
| October 31, 2022 | 76.63% |
| September 30, 2022 | 75.61% |
| August 31, 2022 | 67.55% |
| July 31, 2022 | 64.83% |
| June 30, 2022 | 64.83% |
| May 31, 2022 | 64.83% |
| April 30, 2022 | 64.83% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| China Pharma Holdings, Inc. | 99.91% |
| China Medicine Corp. | 99.95% |
| Livzon Pharmaceutical Group, Inc. | 27.56% |
| CSPC Pharmaceutical Group Ltd. | 61.21% |
| Luye Pharma Group Ltd. | 65.97% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -34.78 |
| Beta (5Y) | 0.8565 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 44.69% |
| Historical Sharpe Ratio (5Y) | -0.5747 |
| Historical Sortino (5Y) | -1.052 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.50% |